Florida’s surgeon general is accusing the Biden administration of “actively preventing the effective distribution of monoclonal antibody treatments” in the United States.
State Surgeon General Joseph Ladapo made the assertion in a letter Tuesday (Dec. 28) to Secretary of Health and Human Services Xavier Becerra following the administration recently pausing shipments of COVID-19 antibody treatments, arguing they are not effective against the Omicron variant of SARS-CoV-2.
Those halted for distribution were made by drug companies Regeneron and Eli Lilly. However, the federal government continues to supply Sotrovimab, a monoclonal antibody from the company GlaxoSmithKline, which reportedly works against the Omicron variant.